InsightfulValue
← Home

Takeda Pharmaceutical
Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
πŸ“’ Press Releases

Date Press release
2025-05-27 07:30:00 Takeda And Nature Announce Call For Applications Now Open For 2026 Innovators In Science Award
Osaka, japan & cambridge, mass.--(business wire)--applications are now open for the takeda innovators in science award with nature recognizing the groundbreaking research of early-career scientists.
2025-05-14 17:03:00 The New England Journal Of Medicine Publishes Data From Phase 2b Trial Of Oral Orexin Receptor 2 Agonist Oveporexton (tak-861) In People With Narcolepsy Type 1
Osaka, japan & cambridge, mass.--(business wire)--takeda (tse: 4502/nyse:tak) today announced that the new england journal of medicine published data from the phase 2b trial of oveporexton (tak-861) in people with narcolepsy type 1 (nt1). oveporexton is an investigational oral orexin receptor 2 (ox2r)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes nt1. results demonstrated significant improvement in objective and subjective measure.
2025-05-08 02:36:00 Takeda Announces Fy2024 Full Year Results And Fy2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation And Late-stage Pipeline Progress
Osaka, japan--(business wire)--takeda (tokyo:4502/nyse:tak) today announced financial results for fiscal year 2024 (period ended march 31, 2025) with continued strong momentum in growth & launch products offsetting loss of exclusivity impact to drive revenue and core operating profit growth, supported by robust cost management. takeda has built a high-value late-stage pipeline with potentially life-transforming new treatment options for patients. following a positive phase 3 readout for rus.
2025-05-05 08:00:00 Biolife Plasma Services Introduces The New Fresenius Kabi Adaptive Nomogram Across Its U.s. Network Of Plasma Donation Centers
Bannockburn, ill.--(business wire)--biolife plasma services, part of takeda (tse:4502/nyse:tak), today announced that it has begun introducing the new fresenius kabi adaptive nomogram across its u.s. network of plasma donation centers. the new adaptive nomogram is used on the aurora xi plasmapheresis system, which is in more than half of biolife’s u.s. plasma donation centers. this new technology will be running in all biolife donation centers using the aurora xi plasmapheresis system by the en.
2025-04-30 08:05:00 Takeda Awards $13.8 Million To U.s. Nonprofit Partners To Promote Healthy Eating And Expand Stem Education
Cambridge, mass.--(business wire)--takeda has awarded grants to seven nonprofits that share its commitment to creating better health for people and a brighter future for the world.
2025-04-08 07:15:00 QmlvaW52ZW 50IFJlY2Vp dmVzIE1pbG VzdG9uZSBQ YXltZW50IE FzIFRha2Vk YSBNb3Zlcy BNZXphZ2l0 YW1hYiBJbn RvIFBoYXNl IDM=
THVuZCwgc3 dlZGVuIC8g YWNjZXNzIG 5ld3N3aXJl IC8gYXByaW wgOCwgMjAy NSAvIGJpb2 ludmVudCBp bnRlcm5hdG lvbmFsIGFi ICjigJliaW 9pbnZlbnTi gJkpIChuYX NkYXEgc3Rv Y2tob2xtOm JpbnYpLCBh IGJpb3RlY2 ggY29tcGFu eSBmb2N1c2 VkIG9uIHRo ZSBkaXNjb3 ZlcnkgYW5k IGRldmVsb3 BtZW50IG9m IG5vdmVsIG FuZCBmaXJz dC1pbi1jbG FzcyBpbW11 bmUtbW9kdW xhdG9yeSBh bnRpYm9kaW VzIGZvciBj YW5jZXIgaW 1tdW5vdGhl cmFweSwgdG 9kYXkgYW5u b3VuY2VzIH RoYXQgaXQg aGFzIGVhcm 5lZCBhIDEg bWlsbGlvbi B1c2QgbWls ZXN0b25lIH BheW1lbnQs IGZvbGxvd2 luZyB0YWtl ZGHigJlzIC h0c2U6NDUw Mi9ueXNlOn RhaykgaW5p dGlhdGlvbi BvZiBwaGFz ZSAzIGNsaW 5pY2FsIHRy aWFsIG9mIG 1lemFnaXRh bWFiICh0YW stMDc5KSwg aWRlbnRpZm llZCBmcm9t IGJpb2ludm VudOKAmXMg cHJvcHJpZX Rhcnkgbi1j b2RlcsKuIG FudGlib2R5 IGxpYnJhcn kuIHRoZSBz dHVkeSBpcy BldmFsdWF0 aW5nIHRoaX MgcG90ZW50 aWFsIGJlc3 QtaW4tY2xh c3MgYW50aS 1jZDgzIG1v bm9jbG9uYW wgYW50aWJv ZHkgZm9yIH BlcnNpc3Rl bnQgb3IgY2 hyb25pYyBw cmltYXJ5IG ltbXVuZSB0 aHJvbWJvY3 l0b3Blbmlh IChpdHApLg ==
2025-03-03 06:45:00 UHJvdGFnb2 5pc3QgQW5k IFRha2VkYS BBbm5vdW5j ZSBQb3NpdG l2ZSBUb3Bs aW5lIFJlc3 VsdHMgRnJv bSBQaGFzZS AzIFZlcmlm eSBTdHVkeS BPZiBSdXNm ZXJ0aWRlIE luIFBhdGll bnRzIFdpdG ggUG9seWN5 dGhlbWlhIF ZlcmE=
TmV3YXJrLC BjYWxpZi4g JiBvc2FrYS wgamFwYW4g JiBjYW1icm lkZ2UsIG1h c3MuLS0oYn VzaW5lc3Mg d2lyZSktLX Byb3RhZ29u aXN0IHRoZX JhcGV1dGlj cywgaW5jLi Ao4oCccHJv dGFnb25pc3 TigJ0pIChu YXNkYXE6cH RneCkgYW5k IHRha2VkYS AodHNlOjQ1 MDIvbnlzZT p0YWspIHRv ZGF5IGFubm 91bmNlZCBw b3NpdGl2ZS B0b3BsaW5l IHJlc3VsdH MgZm9yIHRo ZSBwaGFzZS AzIHZlcmlm eSBzdHVkeS wgaW4gd2hp Y2ggcGhsZW JvdG9teS1k ZXBlbmRlbn QgcGF0aWVu dHMgd2l0aC Bwb2x5Y3l0 aGVtaWEgdm VyYSAocHYp IHdlcmUgcm FuZG9taXpl ZCB0byB0cm VhdG1lbnQg d2l0aCBlaX RoZXIgcnVz ZmVydGlkZS BvciBwbGFj ZWJvLCBhcy BhbiBhZGQt b24gdG8gc3 RhbmRhcmQg b2YgY2FyZS B0cmVhdG1l bnQuIHRoZS BzdHVkeSBt ZXQgaXRzIH ByaW1hcnkg ZW5kcG9pbn QgYW5kIGFs bCBmb3VyIG tleSBzZWNv bmRhcnkgZW 5kcG9pbnRz LiBydXNmZX J0aWRlIGlz IGEgZmlyc3 Qu
2025-02-24 03:01:00 VGhlIEV1cm 9wZWFuIE1l ZGljaW5lcy BBZ2VuY3kg KGVtYSkgSG FzIEFwcHJv dmVkIEFuIE FkZGl0aW9u YWwgU3ViY3 V0YW5lb3Vz IEFkbWluaX N0cmF0aW9u IE9wdGlvbi BGb3IgVGFr aHp5cm/Cri AobGFuYWRl bHVtYWIpIE ZvciBQYXRp ZW50cyBBZ2 VkIDEyIFll YXJzIEFuZC BBYm92ZSBX aXRoIFJlY3 VycmVudCBB dHRhY2tzIE 9mIEhlcmVk aXRhcnkgQW 5naW9lZGVt YSAoaGFlKQ ==
VGFraHp5cm 8gc29sdXRp b24gZm9yIG luamVjdGlv biBpbiAyIG 1sIHByZS1m aWxsZWQgcG VuIGlzIG5v dyBhcHByb3 ZlZCB0byBm YWNpbGl0YX RlIHN1YmN1 dGFuZW91cy BhZG1pbmlz dHJhdGlvbi BpbiBhZG9s ZXNjZW50IC hhZ2VkIDEy IHllYXJzIG FuZCBhYm92 ZSkgYW5kIG FkdWx0IHBh dGllbnRzIH dpdGggaGFl LjEgdGhlIH ByZS1maWxs ZWQgcGVuIG 9wdGlvbiBp cyBkZXNpZ2 5lZCB0byBh bGxvdyBmb3 IgYW4gaW5k aXZpZHVhbG l6ZWQgdHJl YXRtZW50IG FwcHJvYWNo IGZvciBhZG 9sZXNjZW50 IGFuZCBhZH VsdCBoYWUg cGF0aWVudH MuIGluIHRo ZSBldSwgdG FraHp5cm8g aXMgYXBwcm 92ZWQgZm9y IHJvdXRpbm UgcHJldmVu dGlvbiBvZi ByZWN1cnJl bnQgaGFlIG F0dGFja3Mg aW4gcGF0aW VudHMgYWdl ZCAyIHllYX JzIGFuZCBv bGRlci4xIH p1cmljaCAs IGZlYi4gMj QsIDIwMjUg L3BybmV3c3 dpcmUvIC0t IHRha2VkYS AodHNlOiA0 NTAyKSAobn lzZTogdGFr KSBhbm5vdW 5jZWQgdG9k YXkgdGhhdC B0aGUgZW1h IGhhcyBhcH Byb3ZlZCBh biBhZGRpdG lvbmFsIDIg bWwgcHJlLW ZpbGxlZCBw ZW4gb3B0aW 9uIGZvciB0 YWtoenlyb8 KuIChsYW5h ZGVsdW1hYi kgZm9yIHN1 YmN1dGFuZW 91cyBhZG1p bmlzdHJhdG lvbiBpbiBh ZG9sZXNjZW 50cyAoYWdl ZCAxMiB5ZW FycyBhbmQg YWJvdmUpIG FuZCBhZHVs dCBwYXRpZW 50cyB3aXRo IGhlcmVkaX RhcnkgYW5n aW9lZGVtYS AoaGFlKS4x IHRoZSBhZG RpdGlvbmFs IHN1YmN1dG FuZW91cyBh ZG1pbmlzdH JhdGlvbiBv cHRpb24gZX hwYW5kcyB0 YWtlZGHigJ lzIG9mZmVy aW5nIGluIH RoaXMgc3Bh Y2UsIHNob3 dpbmcgZGVk aWNhdGlvbi B0byB0aGUg aGFlIGNvbW 11bml0eSB3 aGlsZSBwcm 92aWRpbmcg aW5kaXZpZH VhbGl6ZWQg dHJlYXRtZW 50IG9wdGlv bnMgdG8gc3 VwcG9ydCBw YXRpZW50cy B3aXRoIGEg bGlmZS10aH JlYXRlbmlu ZyBkaXNlYX NlLCBieSBo ZWxwaW5nIH RvIHJlZHVj ZSBoYWUgYn VyZGVuIGFu ZCBpbXByb3 ZpbmcgdGhl aXIgcXVhbG l0eSBvZiBs aWZlLg==
2025-01-30 09:00:00 U3VmZm9say BDZWxlYnJh dGVzIFRvcH BpbmcgT2Zm IEZvciBBIE dhbWUtY2hh bmdpbmcgTm V3IFRha2Vk YSBGYWNpbG l0eSBJbiBL ZW5kYWxsIF NxdWFyZSBX aGVyZSBTY2 llbmNlLCBB cnQgQW5kIE NvbW11bml0 eSBXaWxsIE NvbnZlcmdl
Qm9zdG9uLS 0oYnVzaW5l c3Mgd2lyZS ktLXN1ZmZv bGssIG9uZS BvZiB0aGUg bGFyZ2VzdC BhbmQgbW9z dCBpbm5vdm F0aXZlIHJl YWwgZXN0YX RlIGFuZCBj b25zdHJ1Y3 Rpb24gZW50 ZXJwcmlzZX MgaW4gdGhl IGNvdW50cn ksIHJlY2Vu dGx5IGNlbG VicmF0ZWQg dG9wcGluZy BvZmYgNTg1 IGtlbmRhbG wuIGRlc2ln bmVkIGJ5IG NidCBhcmNo aXRlY3RzLC A1ODUga2Vu ZGFsbCBpcy BhIG1peGVk LXVzZSBsYW Ivb2ZmaWNl IGJ1aWxkaW 5nIGFuZCBw ZXJmb3JtaW 5nIGFydHMg Y2VudGVyIG luIHRoZSBj YW5hbCBkaX N0cmljdCBv ZiBrZW5kYW xsIHNxdWFy ZS4gdGhlIG V2ZW50IHJl Y29nbml6ZW QgdGhlIGNv bnN0cnVjdG lvbiB0ZWFt cyB0aGF0IH BsYXllZCBh IHZpdGFsIH JvbGUgaW4g cmVhY2hpbm cgdGhpcyBz aWduaWZpY2 FudCBtaWxl c3RvbmUuIH Rha2VkYSBo YXMgbGVhc2 VkIHRoZSBw cm9wZXJ0ee KAmXMgYXBw cm94aW1hdG VseSA2MDAs MDAwLXNxdW FyZS1mb290 IG9mIGxhLg ==
2025-01-30 02:04:00 SnVsaWUgS2 ltIFdpbGwg U3VjY2VlZC BDaHJpc3Rv cGhlIFdlYm VyIEFzIENl byBPZiBUYW tlZGEgSW4g SnVuZSAyMD I2
T3Nha2EsIG phcGFuICYg Y2FtYnJpZG dlLCBtYXNz Li0tKGJ1c2 luZXNzIHdp cmUpLS10YW tlZGEgKHRv a3lvOjQ1MD IvbnlzZTp0 YWspIGFubm 91bmNlZCB0 b2RheSB0aG F0IGl0cyBi b2FyZCBvZi BkaXJlY3Rv cnMgbWFkZS B0aGUgZGVj aXNpb24gdW 5hbmltb3Vz bHkgdG8gYX Bwb2ludCBq dWxpZSBraW 0sIGN1cnJl bnRseSBwcm VzaWRlbnQg b2YgdGFrZW Rh4oCZcyB1 LnMuIGJ1c2 luZXNzIHVu aXQsIGFzIH RoZSBzdWNj ZXNzb3IgdG 8gY2hyaXN0 b3BoZSB3ZW JlciwgdGFr ZWRh4oCZcy BwcmVzaWRl bnQsIGNoaW VmIGV4ZWN1 dGl2ZSBvZm ZpY2VyIChj ZW8pIGFuZC ByZXByZXNl bnRhdGl2ZS BkaXJlY3Rv ciwgd2hlbi Btci4gd2Vi ZXIgcmV0aX JlcyBmcm9t IHRoZSBjb2 1wYW55IGlu IGp1bmUgMj AyNi4gbXJz LiBraW0gd2 lsbCBiZSBw cm9wb3NlZC BhcyBhIGNh bmRpZGF0ZS Bmb3IgZWxl Y3Rpb24gdG 8gdGhlIGJv YXJkIGF0IH Rha2VkYeKA mXMgYW5udW FsIGdlbmVy YWwgc2hhcm Voby4=
2025-01-30 01:35:00 VGFrZWRhIE RlbGl2ZXJz IFN0cm9uZy BUaGlyZC1x dWFydGVyIE Z5MjAyNCBS ZXN1bHRzOy BSYWlzZXMg RnVsbCBZZW FyIE91dGxv b2ssIEZvcm VjYXN0aW5n IFJldmVudW UgQW5kIENv cmUgT3Blcm F0aW5nIFBy b2ZpdCBNYX JnaW4gR3Jv d3Ro
T3Nha2EsIG phcGFuLS0o YnVzaW5lc3 Mgd2lyZSkt LXRha2VkYS AodG9reW86 NDUwMi9ueX NlOnRhaykg dG9kYXkgYW 5ub3VuY2Vk IGVhcm5pbm dzIHJlc3Vs dHMgZm9yIH RoZSB0aGly ZCBxdWFydG VyIG9mIGZp c2NhbCB5ZW FyIDIwMjQg KG5pbmUgbW 9udGhzIGVu ZGVkIGRlY2 VtYmVyIDMx LCAyMDI0KS BzaG93aW5n IGNvbnRpbn VlZCBhZHZh bmNlbWVudC BvZiBpdHMg Z3Jvd3RoIC YgbGF1bmNo IHByb2R1Y3 RzLCB3aGlj aCBkZWxpdm VyZWQgZG91 YmxlLWRpZ2 l0IGdyb3d0 aCBvZiAxNC 42JSBhdCBj ZXIuIHRoZS Bjb21wYW55 IGhhcyB1cG dyYWRlZCBp dHMgZnVsbC B5ZWFyIG91 dGxvb2sgZm 9yIGdyb3d0 aCwgcmVmbG VjdGluZyBz dHJvbmcgeW Vhci10by1k YXRlIHByb2 R1Y3QgcGVy Zm9ybWFuY2 UgYW5kIG9w ZXggZWZmaW NpZW5jaWVz LCBhcyB3ZW xsIGFzIHJl dmlzZWQgZm 9yZWlnbiBl eGNoYW5nZS Bhc3N1bXB0 aW9ucy4gdG FrZWRhIGNv bnRpbnVlcy B0byBhZHZh Lg==
2025-01-27 16:05:00 TmV1cm9jcm luZSBCaW9z Y2llbmNlcy BBbm5vdW5j ZXMgQW1lbm RtZW50IFRv IFN0cmF0ZW dpYyBDb2xs YWJvcmF0aW 9uIFdpdGgg VGFrZWRhIF RvIERldmVs b3AgQW5kIE NvbW1lcmNp YWxpemUgT3 NhdmFtcGF0 b3IgKGZvcm 1lcmx5IE5i aS0xMDY1OD Q1L3Rhay02 NTMp
LcKgwqDCoM KgwqDCoCBu ZXVyb2NyaW 5lIG9idGFp bnMgZXhjbH VzaXZlIHdv cmxkd2lkZS BkZXZlbG9w bWVudCBhbm QgY29tbWVy Y2lhbGl6YX Rpb24gcmln aHRzIGV4Y2 x1ZGluZyBq YXBhbiBhbm QgY29udmVy dHMgdG8gcm 95YWx0eS1i ZWFyaW5nIG xpY2Vuc2Ug Zm9yIG9zYX ZhbXBhdG9y IC3CoMKgwq DCoMKgwqAg dGFrZWRhIH JlYWNxdWly ZXMgcmlnaH RzIHRvIG9z YXZhbXBhdG 9yIGluIGph cGFuIHNhbi BkaWVnbyAs IGphbi4gMj csIDIwMjUg L3BybmV3c3 dpcmUvIC0t IG5ldXJvY3 JpbmUgYmlv c2NpZW5jZX MsIGluYy4g KG5hc2RhcT ogbmJpeCkg dG9kYXkgYW 5ub3VuY2Vk IGl0IGhhcy BhbWVuZGVk IGl0cyBhZ3 JlZW1lbnQg d2l0aCB0YW tlZGEgdG8g ZGV2ZWxvcC BhbmQgY29t bWVyY2lhbG l6ZSBvc2F2 YW1wYXRvci AobmJpLTEw NjU4NDUvdG FrLTY1Myku IHVuZGVyIH RoZSBhbWVu ZGVkIGFncm VlbWVudCwg bmV1cm9jcm luZSB3aWxs IG9idGFpbi BleGNsdXNp dmUgcmlnaH RzIGZvciBh bGwgaW5kaW NhdGlvbnMg dG8gZGV2ZW xvcCBhbmQg Y29tbWVyY2 lhbGl6ZSBv c2F2YW1wYX RvciwgYSBw b3RlbnRpYW wgZmlyc3Qt aW4tY2xhc3 MgYW1wYSBw b3NpdGl2ZS BhbGxvc3Rl cmljIG1vZH VsYXRvciBp biBkZXZlbG 9wbWVudCBm b3IgcGF0aW VudHMgd2l0 aCBpbmFkZX F1YXRlIHJl c3BvbnNlIH RvIHRyZWF0 bWVudCBvZi BtYWpvciBk ZXByZXNzaX ZlIGRpc29y ZGVyIChtZG QpIGluIGFs bCB0ZXJyaX RvcmllcyB3 b3JsZHdpZG UgZXhjZXB0 IGphcGFuLC B3aGVyZSB0 YWtlZGEgd2 lsbCByZWFj cXVpcmUgZX hjbHVzaXZl IHJpZ2h0cy 4=
2024-12-27 01:00:00 VGFrZWRhIE Fubm91bmNl cyBBcHByb3 ZhbCBPZiBI eXF2aWHCri AxMCUgUy5j LiAoc3ViY3 V0YW5lb3Vz KSBJbmplY3 Rpb24gU2V0 IEluIEphcG FuIEZvciBQ YXRpZW50cy BXaXRoIEFn YW1tYWdsb2 J1bGluZW1p YSBPciBIeX BvZ2FtbWFn bG9idWxpbm VtaWE=
T3Nha2EsIG phcGFuICYg Y2FtYnJpZG dlLCBtYXNz Li0tKGJ1c2 luZXNzIHdp cmUpLS10YW tlZGEgKHRz ZTo0NTAyL2 55c2U6dGFr KSB0b2RheS Bhbm5vdW5j ZWQgdGhhdC B0aGUgamFw YW5lc2UgbW luaXN0cnkg b2YgaGVhbH RoLCBsYWJv dXIgYW5kIH dlbGZhcmUg aGFzIGFwcH JvdmVkIHRo ZSB1c2Ugb2 YgaHlxdmlh wq4gW2ltbX VuZSBnbG9i dWxpbiBpbm Z1c2lvbiAx MCUgKGh1bW FuKSB3aXRo IHJlY29tYm luYW50IGh1 bWFuIGh5YW x1cm9uaWRh c2VdIGluIH BhdGllbnRz IHdpdGggYW dhbW1hZ2xv YnVsaW5lbW lhIG9yIGh5 cG9nYW1tYW dsb2J1bGlu ZW1pYTEsIG Rpc29yZGVy cyBjaGFyYW N0ZXJpemVk IGJ5IHZlcn kgbG93IG9y IGFic2VudC BsZXZlbHMg b2YgYW50aW JvZGllcyBh bmQgYW4gaW 5jcmVhc2Vk IHJpc2sgb2 Ygc2VyaW91 cyByZWN1cn JpbmcgaW5m ZWN0aW9uIG NhdXNlZCBi eSBwcmltYX J5IGltbXVu b2RlZmljaW VuY3kgKHBp ZCkgb3Igc2 Vjb25kYXJ5 IGltbXUu
2024-12-03 07:00:00 VGFrZWRhIF N0cmVuZ3Ro ZW5zIE9uY2 9sb2d5IFBp cGVsaW5lIF dpdGggRWxy aXRlcmNlcH QgVGhyb3Vn aCBMaWNlbn NpbmcgQWdy ZWVtZW50IF dpdGggS2Vy b3MgVGhlcm FwZXV0aWNz
T3Nha2EsIG phcGFuICYg Y2FtYnJpZG dlLCBtYXNz Li0tKGJ1c2 luZXNzIHdp cmUpLS10YW tlZGEgKHRz ZTo0NTAyL2 55c2U6dGFr KSB0b2RheS Bhbm5vdW5j ZWQgdGhhdC BpdCBoYXMg ZW50ZXJlZC BpbnRvIGFu IGV4Y2x1c2 l2ZSBsaWNl bnNpbmcgYW dyZWVtZW50 IHdpdGgga2 Vyb3MgdGhl cmFwZXV0aW NzLCBpbmMu IChuYXNkYX E6IGtyb3Mp IHRvIGZ1cn RoZXIgZGV2 ZWxvcCwgbW FudWZhY3R1 cmUgYW5kIG NvbW1lcmNp YWxpemUgZW xyaXRlcmNl cHQgd29ybG R3aWRlIG91 dHNpZGUgb2 YgbWFpbmxh bmQgY2hpbm EsIGhvbmcg a29uZyBhbm QgbWFjYXUu IGVscml0ZX JjZXB0IGlz IGEgbGF0ZS 1zdGFnZSBp bnZlc3RpZ2 F0aW9uYWwg YWN0aXZpbi BpbmhpYml0 b3IgZGVzaW duZWQgdG8g dHJlYXQgYW 5lbWlhIGFz c29jaWF0ZW Qgd2l0aCBj ZXJ0YWluIG hlbWF0b2xv Z2ljIGNhbm NlcnMsIGlu Y2x1ZGluZy BteWVsb2R5 c3BsYXN0aW Mgc3luZHJv bWVzIChtZH MpIGFuZCBt eWVsby4=
2024-11-20 11:30:00 QWxsb3kgVG hlcmFwZXV0 aWNzIFNpZ2 5zIENvbGxh Ym9yYXRpb2 4gQW5kIExp Y2Vuc2UgQW dyZWVtZW50 IFdpdGggVG FrZWRhIFRv IERldmVsb3 AgQ2VsbCBU aGVyYXB5IF BsYXRmb3Jt
VG9reW8gJi Bib3N0b24t LShidXNpbm VzcyB3aXJl KS0tYWxsb3 kgdGhlcmFw ZXV0aWNzIG luYy4gKOKA nGFsbG954o CdKSwgYSBi aW90ZWNobm 9sb2d5IGVj b3N5c3RlbS Bjb21wYW55 IGRlZGljYX RlZCB0byBk ZW1vY3JhdG l6aW5nIGFj Y2VzcyB0by BjdXR0aW5n IGVkZ2UgZH J1ZyBkaXNj b3ZlcnkgdG VjaG5vbG9n aWVzLCBhbm 5vdW5jZWQg dG9kYXkgYS BzdHJhdGVn aWMgY29sbG Fib3JhdGlv biBhbmQgbG ljZW5zZSBh Z3JlZW1lbn Qgd2l0aCB0 YWtlZGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSBs aW1pdGVkIC h0c2U6NDUw Mi9ueXNlOn RhayDigJx0 YWtlZGHigJ 0pIHRvIGRl dmVsb3AgdG FrZWRh4oCZ cyBwcm9wcm lldGFyeSBp bmR1Y2VkIH BsdXJpcG90 ZW50IHN0ZW 0gY2VsbCAo aXBzYykgZG VyaXZlZCBj YXItdCBjZW xsIHBsYXRm b3JtIChpY2 FyLXQpIGFu ZCBpcHNjLW Rlcml2ZWQg Y2FyLW5rIH BsYXRmb3Jt IChpY2FyLW 5rKS4gYWxs b3kgd2lsbC Bmb2N1cyBv biBhY2NlbG VyYXRpbmcu
Takeda Pharmaceutical

πŸ“° Browse additional press releases for Takeda Pharmaceutical!

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal